A new interactive mobile phone app called DiabetesIQ challenges people to test their knowledge of diabetes and to compete with one another as they learn about the complexities of the disease.
September 26, 2011
September 13, 2011
A survey of federally funded diabetes prevention and control programs in 57 U.S. states and territories has highlighted the need for better diabetes treatment guidelines that are specifically adapted to different populations. Such guidelines do not currently exist.
September 06, 2011
A somewhat mysterious soft tissue found in the fetus during early development in the womb plays a pivotal role in the formation of mature beta cells the sole source of the body’s insulin. This discovery, made by scientists at University of California, San Francisco (UCSF) and Texas A&M University, may lead to new ways of addressing Type 1 and Type 2 diabetes.
June 28, 2011
The UCSF Diabetes Family Fund for Innovative Patient Care, Education and Scientific Discovery, created by one anonymous donor who is committed to diabetes research, is financing 11 projects that support creative, collaborative and imaginative innovations in diabetes clinical care, patient education, medical training and clinical and basic research.
May 23, 2011
Experts at UCSF and Caltech are pushing the boundaries of creative problem solving to address important clinical problems with the hope that the talent pool at both institutions, combined with an entrepreneurial spirit, will advance health care innovation.
March 01, 2011
Scientists at the UCSF Cardiovascular Research Institute have discovered how a change in growth hormone activity in mice leads to fatty liver disease, a condition whose human counterpart is of rising concern worldwide.
March 01, 2011
A multinational study has identified a key gene mutation responsible for type 2 diabetes, a finding that could lead to developing a predictive test for the disease, identifying which current medications work best and driving pharmaceutical research to find new therapies.
February 24, 2011
Among those cheering the recent opening of the new stem cell science building at UCSF were two patient advocates who have a personal connection to advancing the field of regenerative medicine.
February 23, 2011
UCSF pediatric endocrinologist Steve Gitelman leads type 1 diabetes clinical trials with the goal of halting beta cell destruction and thereby stopping the progression of disease soon after it is diagnosed.
February 11, 2011
Leading scientists from California companies discussed groundbreaking clinical trials of stem cell therapies during a recent scientific symposium to celebrate the opening of the Ray and Dagmar Dolby Regeneration Medicine Building at UCSF.